About
Synaptiflora is an AI-powered microbiome intelligence startup building a foundational platform to understand and predict how the human microbiome influences drug response, disease biology, and product performance across industries.
The platform combines strain-level microbiome indexing, a proprietary ex vivo high-throughput screening system, and machine-learning models trained on large human microbiome datasets. Together, these technologies connect raw microbiome data to real biological mechanisms—revealing how microbes metabolize compounds, modulate immunity, and alter therapeutic outcomes.
Synaptiflora’s initial focus is pharmaceutical R&D, helping partners improve clinical trial success, patient stratification, and drug efficacy by accounting for microbiome-driven variability. The same intelligence layer extends to nutrition, cosmetics, and agriculture, enabling microbiome-aware product design and innovation.
At its core, Synaptiflora turns the microbiome from an unexplained source of noise into a predictive, actionable system for building better, more precise products.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Synaptiflora founded?
- Synaptiflora was founded in September 2024.
- What is Synaptiflora's primary focus?
- Synaptiflora's initial focus is pharmaceutical R&D, aiming to improve clinical trial success, patient stratification, and drug efficacy by accounting for microbiome-driven variability.
- What technology does Synaptiflora use in its platform?
- Synaptiflora's platform combines strain-level microbiome indexing, a proprietary ex vivo high-throughput screening system, and machine-learning models trained on large human microbiome datasets.
- What is the current funding stage of Synaptiflora?
- Synaptiflora is currently in the Pre-Funding stage.
- How many employees does Synaptiflora have?
- Synaptiflora has 3 employees.
- Where is Synaptiflora headquartered?
- Synaptiflora is headquartered in Haifa, Israel.
- Who are the founders of Synaptiflora?
- The founders of Synaptiflora are Valeriia Ivanona and Shaul Sapielkin.
- What markets does Synaptiflora target geographically?
- Synaptiflora targets geographic markets including Europe, the United States, and Israel.
- What is the primary sector of Synaptiflora?
- Synaptiflora's primary sector is Health Tech & Life Sciences.